Top Markets
#1 Black Phoenix Black Phoenix +827.90%
#2 PondCoin PondCoin +36.19%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.74%
#4 pipedog pipedog +28.59%
#5 SAFEcoin SAFEcoin +26.68%
#6 Bless Bless +24.96%
#7 Beam Beam +21.97%
#8 Seeker Seeker +21.81%
#9 Magma Finance Magma Finance +19.13%
#10 YFSX YFSX +16.11%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rank in Stocks #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Share Price
$64.97
Last synced: 2024-05-20
Market Cap
$1.97B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Alpine Immune Sciences, Inc. (ALPN)

Category

Healthcare
Number of shares outstanding for Alpine Immune Sciences, Inc. (ALPN)
Number of shares outstanding as of March 2024: 64.03M
According to Alpine Immune Sciences, Inc. latest financial reports and stock price the company's current number of shares outstanding is 64.03M. At the end of December 2022 the company had 33.44M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Alpine Immune Sciences, Inc. (ALPN) from 2012 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 64.03M 28.07%
2023 50.00M 49.54%
2022 33.44M 31.24%
2021 25.48M 22.33%
2020 20.83M 13.44%
2019 18.36M 32.56%
2018 13.85M 113.67%
2017 6.48M 67.36%
2016 3.87M 65.32%
2015 2.34M 2.70%
2014 2.28M 0.00%
2013 2.28M 0.00%
2012 2.28M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 296.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -2.89%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 647.91%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 518.43%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH